Rankings
▼
Calendar
NVCR Q4 2019 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q4 2019 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$99M
+42.4% YoY
Gross Profit
$74M
75.0% margin
Operating Income
$152,000
0.2% margin
Net Income
$4M
4.3% margin
EPS (Diluted)
$0.04
QoQ Revenue Growth
+7.8%
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
$4M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$479M
Total Liabilities
$262M
Stockholders' Equity
$218M
Cash & Equivalents
$179M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$99M
$70M
+42.4%
Gross Profit
$74M
$47M
+59.6%
Operating Income
$152,000
-$9M
+101.8%
Net Income
$4M
-$16M
+127.3%
Geographic Segments
UNITED STATES
$66M
187%
GERMANY
$22M
64%
JAPAN
$6M
16%
CHINA
$2M
6%
EMEA
-$61M
-173%
← FY 2019
All Quarters
Q1 2020 →